Beta Bionics Insider Sells Over $63,000 in Stock

Mark Hopman, a Beta Bionics insider, sold 2,061 shares of the company's stock.

Mar. 18, 2026 at 9:05am

Got story updates? Submit your updates here. ›

Beta Bionics, Inc. (NASDAQ:BBNX) insider Mark Hopman sold 2,061 shares of the firm's stock in a transaction on Thursday, December 4th. The stock was sold at an average price of $30.66, for a total value of $63,190.26. Following the transaction, Hopman directly owned 136,216 shares in the company, valued at approximately $4,176,382.56.

Why it matters

This insider sale represents a 1.49% decrease in Hopman's position in Beta Bionics. Insider transactions can provide insights into a company's performance and management's confidence in the business.

The details

Hopman sold the 2,061 shares of Beta Bionics stock on December 4th. The shares were sold at an average price of $30.66, resulting in total proceeds of $63,190.26. After the sale, Hopman still directly owns 136,216 shares in the company, valued at approximately $4,176,382.56.

  • The shares were sold on Thursday, December 4th.

The players

Mark Hopman

An insider at Beta Bionics, Inc. (NASDAQ:BBNX).

Beta Bionics, Inc.

A clinical-stage medical device company headquartered in Boston, Massachusetts, focused on revolutionizing the management of type 1 diabetes through automated insulin delivery solutions.

Got photos? Submit your photos here. ›

The takeaway

This insider sale by Mark Hopman provides insight into the current state of Beta Bionics and may signal management's confidence or concerns about the company's future performance.